nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.0144	0.108	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.01	0.0755	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.01	0.0755	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.01	0.0755	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.00974	0.0732	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00846	0.0636	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00612	0.046	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00437	0.0329	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00378	0.0284	CbGpPWpGaD
Melphalan—SLC7A5—Desoximetasone—Methylprednisolone—multiple sclerosis	0.0034	0.174	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Betamethasone—multiple sclerosis	0.00335	0.172	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Dexamethasone—multiple sclerosis	0.00335	0.172	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Triamcinolone—multiple sclerosis	0.00327	0.168	CbGdCrCtD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00321	0.0242	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00316	0.0238	CbGpPWpGaD
Melphalan—SLC7A5—Desoximetasone—Prednisone—multiple sclerosis	0.0031	0.159	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Prednisolone—multiple sclerosis	0.00303	0.155	CbGdCrCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00287	0.0215	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MERTK—multiple sclerosis	0.00272	0.0205	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SELPLG—multiple sclerosis	0.00272	0.0205	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CD58—multiple sclerosis	0.00272	0.0205	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.00263	0.0198	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00235	0.0176	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.00234	0.0176	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00224	0.0169	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.002	0.0151	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00193	0.0145	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00192	0.0144	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.00182	0.0137	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.0017	0.0128	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLEK—multiple sclerosis	0.00168	0.0126	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00146	0.011	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00146	0.011	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SELE—multiple sclerosis	0.00119	0.00891	CbGpPWpGaD
Melphalan—Skin disorder—Azathioprine—multiple sclerosis	0.00116	0.00136	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00115	0.00866	CbGpPWpGaD
Melphalan—Haemoglobin—Prednisolone—multiple sclerosis	0.00112	0.00132	CcSEcCtD
Melphalan—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00112	0.00132	CcSEcCtD
Melphalan—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00111	0.00131	CcSEcCtD
Melphalan—Hypotension—Azathioprine—multiple sclerosis	0.00111	0.00131	CcSEcCtD
Melphalan—Haemorrhage—Prednisolone—multiple sclerosis	0.00111	0.00131	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—multiple sclerosis	0.00111	0.00131	CcSEcCtD
Melphalan—Anaemia—Mitoxantrone—multiple sclerosis	0.00109	0.00129	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00109	0.00128	CcSEcCtD
Melphalan—Hypersensitivity—Cladribine—multiple sclerosis	0.00108	0.00127	CcSEcCtD
Melphalan—Renal failure acute—Methotrexate—multiple sclerosis	0.00106	0.00125	CcSEcCtD
Melphalan—Leukopenia—Mitoxantrone—multiple sclerosis	0.00106	0.00125	CcSEcCtD
Melphalan—Asthenia—Cladribine—multiple sclerosis	0.00105	0.00124	CcSEcCtD
Melphalan—Pruritus—Cladribine—multiple sclerosis	0.00104	0.00122	CcSEcCtD
Melphalan—Cough—Mitoxantrone—multiple sclerosis	0.00103	0.00121	CcSEcCtD
Melphalan—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00103	0.00121	CcSEcCtD
Melphalan—Haemoglobin—Triamcinolone—multiple sclerosis	0.00103	0.00121	CcSEcCtD
Melphalan—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00103	0.00121	CcSEcCtD
Melphalan—Haemorrhage—Triamcinolone—multiple sclerosis	0.00102	0.00121	CcSEcCtD
Melphalan—Convulsion—Mitoxantrone—multiple sclerosis	0.00102	0.00121	CcSEcCtD
Melphalan—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00102	0.0012	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00102	0.00767	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00102	0.00765	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.00101	0.0012	CcSEcCtD
Melphalan—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.00101	0.0012	CcSEcCtD
Melphalan—Myalgia—Mitoxantrone—multiple sclerosis	0.001	0.00119	CcSEcCtD
Melphalan—Chest pain—Mitoxantrone—multiple sclerosis	0.001	0.00119	CcSEcCtD
Melphalan—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.001	0.00118	CcSEcCtD
Melphalan—Diarrhoea—Cladribine—multiple sclerosis	0.001	0.00118	CcSEcCtD
Melphalan—Arrhythmia—Prednisolone—multiple sclerosis	0.000993	0.00117	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000979	0.00736	CbGpPWpGaD
Melphalan—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000963	0.00114	CcSEcCtD
Melphalan—Oedema—Mitoxantrone—multiple sclerosis	0.000963	0.00114	CcSEcCtD
Melphalan—Infection—Mitoxantrone—multiple sclerosis	0.000956	0.00113	CcSEcCtD
Melphalan—Neutropenia—Prednisone—multiple sclerosis	0.000944	0.00111	CcSEcCtD
Melphalan—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000943	0.00111	CcSEcCtD
Melphalan—Tachycardia—Mitoxantrone—multiple sclerosis	0.00094	0.00111	CcSEcCtD
Melphalan—Skin disorder—Mitoxantrone—multiple sclerosis	0.000935	0.0011	CcSEcCtD
Melphalan—Haemoglobin—Dexamethasone—multiple sclerosis	0.000932	0.0011	CcSEcCtD
Melphalan—Haemoglobin—Betamethasone—multiple sclerosis	0.000932	0.0011	CcSEcCtD
Melphalan—Vomiting—Cladribine—multiple sclerosis	0.000931	0.0011	CcSEcCtD
Melphalan—Haemorrhage—Betamethasone—multiple sclerosis	0.000928	0.00109	CcSEcCtD
Melphalan—Haemorrhage—Dexamethasone—multiple sclerosis	0.000928	0.00109	CcSEcCtD
Melphalan—Rash—Cladribine—multiple sclerosis	0.000924	0.00109	CcSEcCtD
Melphalan—Dermatitis—Cladribine—multiple sclerosis	0.000923	0.00109	CcSEcCtD
Melphalan—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000921	0.00109	CcSEcCtD
Melphalan—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000919	0.00108	CcSEcCtD
Melphalan—Anorexia—Mitoxantrone—multiple sclerosis	0.000918	0.00108	CcSEcCtD
Melphalan—Arrhythmia—Triamcinolone—multiple sclerosis	0.000913	0.00108	CcSEcCtD
Melphalan—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000911	0.00108	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000901	0.00106	CcSEcCtD
Melphalan—Hypotension—Mitoxantrone—multiple sclerosis	0.0009	0.00106	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000882	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Azathioprine—multiple sclerosis	0.000877	0.00104	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000877	0.00103	CcSEcCtD
Melphalan—Nausea—Cladribine—multiple sclerosis	0.00087	0.00103	CcSEcCtD
Melphalan—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000865	0.00102	CcSEcCtD
Melphalan—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000858	0.00101	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ITGA4—multiple sclerosis	0.000857	0.00644	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IFNB1—multiple sclerosis	0.00085	0.0064	CbGpPWpGaD
Melphalan—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000847	0.001	CcSEcCtD
Melphalan—Convulsion—Prednisolone—multiple sclerosis	0.000839	0.000989	CcSEcCtD
Melphalan—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000837	0.000988	CcSEcCtD
Melphalan—Fatigue—Mitoxantrone—multiple sclerosis	0.00083	0.000979	CcSEcCtD
Melphalan—Arrhythmia—Dexamethasone—multiple sclerosis	0.000829	0.000978	CcSEcCtD
Melphalan—Arrhythmia—Betamethasone—multiple sclerosis	0.000829	0.000978	CcSEcCtD
Melphalan—Pain—Mitoxantrone—multiple sclerosis	0.000823	0.000971	CcSEcCtD
Melphalan—Alopecia—Dexamethasone—multiple sclerosis	0.00082	0.000967	CcSEcCtD
Melphalan—Alopecia—Betamethasone—multiple sclerosis	0.00082	0.000967	CcSEcCtD
Melphalan—Diarrhoea—Azathioprine—multiple sclerosis	0.000815	0.000961	CcSEcCtD
Melphalan—Haemoglobin—Prednisone—multiple sclerosis	0.000812	0.000958	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—multiple sclerosis	0.000808	0.000953	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—multiple sclerosis	0.000801	0.000945	CcSEcCtD
Melphalan—Connective tissue disorder—Prednisone—multiple sclerosis	0.000794	0.000937	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00079	0.000932	CcSEcCtD
Melphalan—Oedema—Prednisolone—multiple sclerosis	0.00079	0.000932	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—multiple sclerosis	0.000789	0.000931	CcSEcCtD
Melphalan—Cough—Triamcinolone—multiple sclerosis	0.000777	0.000916	CcSEcCtD
Melphalan—Convulsion—Triamcinolone—multiple sclerosis	0.000771	0.00091	CcSEcCtD
Melphalan—Tachycardia—Prednisolone—multiple sclerosis	0.000771	0.00091	CcSEcCtD
Melphalan—Convulsion—Methylprednisolone—multiple sclerosis	0.000769	0.000908	CcSEcCtD
Melphalan—Urticaria—Mitoxantrone—multiple sclerosis	0.000765	0.000902	CcSEcCtD
Melphalan—Myalgia—Triamcinolone—multiple sclerosis	0.000758	0.000894	CcSEcCtD
Melphalan—Vomiting—Azathioprine—multiple sclerosis	0.000757	0.000893	CcSEcCtD
Melphalan—Myalgia—Methylprednisolone—multiple sclerosis	0.000756	0.000892	CcSEcCtD
Melphalan—Rash—Azathioprine—multiple sclerosis	0.000751	0.000886	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000751	0.000886	CcSEcCtD
Melphalan—Dermatitis—Azathioprine—multiple sclerosis	0.00075	0.000885	CcSEcCtD
Melphalan—Flushing—Prednisone—multiple sclerosis	0.00075	0.000885	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000742	0.00558	CbGpPWpGaD
Melphalan—Stomatitis—Methotrexate—multiple sclerosis	0.000733	0.000865	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—multiple sclerosis	0.00073	0.000861	CcSEcCtD
Melphalan—Oedema—Triamcinolone—multiple sclerosis	0.000726	0.000857	CcSEcCtD
Melphalan—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000726	0.000857	CcSEcCtD
Melphalan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000725	0.000855	CcSEcCtD
Melphalan—Arrhythmia—Prednisone—multiple sclerosis	0.000722	0.000852	CcSEcCtD
Melphalan—Infection—Triamcinolone—multiple sclerosis	0.000722	0.000851	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000721	0.00542	CbGpPWpGaD
Melphalan—Infection—Methylprednisolone—multiple sclerosis	0.00072	0.00085	CcSEcCtD
Melphalan—Alopecia—Prednisone—multiple sclerosis	0.000714	0.000842	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000711	0.000839	CcSEcCtD
Melphalan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000709	0.000837	CcSEcCtD
Melphalan—Paraesthesia—Prednisolone—multiple sclerosis	0.000709	0.000837	CcSEcCtD
Melphalan—Tachycardia—Triamcinolone—multiple sclerosis	0.000709	0.000836	CcSEcCtD
Melphalan—Nausea—Azathioprine—multiple sclerosis	0.000707	0.000835	CcSEcCtD
Melphalan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000707	0.000835	CcSEcCtD
Melphalan—Skin disorder—Methylprednisolone—multiple sclerosis	0.000704	0.000831	CcSEcCtD
Melphalan—Convulsion—Betamethasone—multiple sclerosis	0.0007	0.000826	CcSEcCtD
Melphalan—Convulsion—Dexamethasone—multiple sclerosis	0.0007	0.000826	CcSEcCtD
Melphalan—Asthenia—Mitoxantrone—multiple sclerosis	0.000691	0.000815	CcSEcCtD
Melphalan—Myalgia—Betamethasone—multiple sclerosis	0.000688	0.000811	CcSEcCtD
Melphalan—Myalgia—Dexamethasone—multiple sclerosis	0.000688	0.000811	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—multiple sclerosis	0.000679	0.000801	CcSEcCtD
Melphalan—Hypotension—Methylprednisolone—multiple sclerosis	0.000677	0.000799	CcSEcCtD
Melphalan—Pain—Prednisolone—multiple sclerosis	0.000675	0.000797	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—multiple sclerosis	0.000675	0.000797	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—multiple sclerosis	0.000675	0.000797	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000667	0.000787	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—multiple sclerosis	0.000662	0.000781	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000662	0.000781	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00066	0.000779	CcSEcCtD
Melphalan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000659	0.000778	CcSEcCtD
Melphalan—Oedema—Dexamethasone—multiple sclerosis	0.000659	0.000778	CcSEcCtD
Melphalan—Oedema—Betamethasone—multiple sclerosis	0.000659	0.000778	CcSEcCtD
Melphalan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000659	0.000778	CcSEcCtD
Melphalan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000659	0.000777	CcSEcCtD
Melphalan—Infection—Betamethasone—multiple sclerosis	0.000655	0.000773	CcSEcCtD
Melphalan—Infection—Dexamethasone—multiple sclerosis	0.000655	0.000773	CcSEcCtD
Melphalan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000652	0.00077	CcSEcCtD
Melphalan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000651	0.000768	CcSEcCtD
Melphalan—Anaemia—Prednisone—multiple sclerosis	0.00065	0.000767	CcSEcCtD
Melphalan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000648	0.000764	CcSEcCtD
Melphalan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000645	0.000761	CcSEcCtD
Melphalan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000645	0.000761	CcSEcCtD
Melphalan—Tachycardia—Dexamethasone—multiple sclerosis	0.000643	0.000759	CcSEcCtD
Melphalan—Tachycardia—Betamethasone—multiple sclerosis	0.000643	0.000759	CcSEcCtD
Melphalan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000639	0.000754	CcSEcCtD
Melphalan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000638	0.000753	CcSEcCtD
Melphalan—Anorexia—Dexamethasone—multiple sclerosis	0.000628	0.000741	CcSEcCtD
Melphalan—Anorexia—Betamethasone—multiple sclerosis	0.000628	0.000741	CcSEcCtD
Melphalan—Urticaria—Prednisolone—multiple sclerosis	0.000627	0.00074	CcSEcCtD
Melphalan—Fatigue—Triamcinolone—multiple sclerosis	0.000626	0.000739	CcSEcCtD
Melphalan—Fatigue—Methylprednisolone—multiple sclerosis	0.000625	0.000737	CcSEcCtD
Melphalan—Pain—Triamcinolone—multiple sclerosis	0.000621	0.000733	CcSEcCtD
Melphalan—Hypotension—Betamethasone—multiple sclerosis	0.000616	0.000727	CcSEcCtD
Melphalan—Hypotension—Dexamethasone—multiple sclerosis	0.000616	0.000727	CcSEcCtD
Melphalan—Vomiting—Mitoxantrone—multiple sclerosis	0.000612	0.000722	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—multiple sclerosis	0.00061	0.00072	CcSEcCtD
Melphalan—Convulsion—Prednisone—multiple sclerosis	0.000609	0.000719	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000609	0.000718	CcSEcCtD
Melphalan—Rash—Mitoxantrone—multiple sclerosis	0.000607	0.000716	CcSEcCtD
Melphalan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000606	0.000716	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SRM—multiple sclerosis	0.000605	0.00455	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.0006	0.000708	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.0006	0.000708	CcSEcCtD
Melphalan—Myalgia—Prednisone—multiple sclerosis	0.000599	0.000706	CcSEcCtD
Melphalan—Alopecia—Methotrexate—multiple sclerosis	0.000597	0.000704	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000595	0.000702	CcSEcCtD
Melphalan—Paraesthesia—Betamethasone—multiple sclerosis	0.000592	0.000698	CcSEcCtD
Melphalan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000592	0.000698	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000586	0.00441	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IL2RA—multiple sclerosis	0.000585	0.0044	CbGpPWpGaD
Melphalan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000582	0.000687	CcSEcCtD
Melphalan—Dyspepsia—Dexamethasone—multiple sclerosis	0.00058	0.000685	CcSEcCtD
Melphalan—Dyspepsia—Betamethasone—multiple sclerosis	0.00058	0.000685	CcSEcCtD
Melphalan—Urticaria—Triamcinolone—multiple sclerosis	0.000577	0.000681	CcSEcCtD
Melphalan—Urticaria—Methylprednisolone—multiple sclerosis	0.000576	0.000679	CcSEcCtD
Melphalan—Oedema—Prednisone—multiple sclerosis	0.000574	0.000677	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—multiple sclerosis	0.000574	0.000677	CcSEcCtD
Melphalan—Decreased appetite—Dexamethasone—multiple sclerosis	0.000573	0.000676	CcSEcCtD
Melphalan—Decreased appetite—Betamethasone—multiple sclerosis	0.000573	0.000676	CcSEcCtD
Melphalan—Nausea—Mitoxantrone—multiple sclerosis	0.000572	0.000675	CcSEcCtD
Melphalan—Infection—Prednisone—multiple sclerosis	0.00057	0.000673	CcSEcCtD
Melphalan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000569	0.000671	CcSEcCtD
Melphalan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000569	0.000671	CcSEcCtD
Melphalan—Fatigue—Dexamethasone—multiple sclerosis	0.000568	0.00067	CcSEcCtD
Melphalan—Fatigue—Betamethasone—multiple sclerosis	0.000568	0.00067	CcSEcCtD
Melphalan—Pain—Dexamethasone—multiple sclerosis	0.000564	0.000665	CcSEcCtD
Melphalan—Pain—Betamethasone—multiple sclerosis	0.000564	0.000665	CcSEcCtD
Melphalan—Tachycardia—Prednisone—multiple sclerosis	0.00056	0.000661	CcSEcCtD
Melphalan—Skin disorder—Prednisone—multiple sclerosis	0.000558	0.000658	CcSEcCtD
Melphalan—Anorexia—Prednisone—multiple sclerosis	0.000547	0.000646	CcSEcCtD
Melphalan—Anaemia—Methotrexate—multiple sclerosis	0.000543	0.000641	CcSEcCtD
Melphalan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000535	0.000631	CcSEcCtD
Melphalan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000534	0.00063	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—multiple sclerosis	0.000526	0.000621	CcSEcCtD
Melphalan—Urticaria—Betamethasone—multiple sclerosis	0.000524	0.000618	CcSEcCtD
Melphalan—Urticaria—Dexamethasone—multiple sclerosis	0.000524	0.000618	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000523	0.000617	CcSEcCtD
Melphalan—Asthenia—Triamcinolone—multiple sclerosis	0.000521	0.000615	CcSEcCtD
Melphalan—Asthenia—Methylprednisolone—multiple sclerosis	0.00052	0.000614	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000518	0.0039	CbGpPWpGaD
Melphalan—Paraesthesia—Prednisone—multiple sclerosis	0.000515	0.000608	CcSEcCtD
Melphalan—Pruritus—Triamcinolone—multiple sclerosis	0.000514	0.000606	CcSEcCtD
Melphalan—Cough—Methotrexate—multiple sclerosis	0.000513	0.000605	CcSEcCtD
Melphalan—Pruritus—Methylprednisolone—multiple sclerosis	0.000513	0.000605	CcSEcCtD
Melphalan—Convulsion—Methotrexate—multiple sclerosis	0.000509	0.000601	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—multiple sclerosis	0.000505	0.000596	CcSEcCtD
Melphalan—Myalgia—Methotrexate—multiple sclerosis	0.0005	0.00059	CcSEcCtD
Melphalan—Chest pain—Methotrexate—multiple sclerosis	0.0005	0.00059	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—multiple sclerosis	0.000499	0.000589	CcSEcCtD
Melphalan—Rash—Prednisolone—multiple sclerosis	0.000498	0.000588	CcSEcCtD
Melphalan—Dermatitis—Prednisolone—multiple sclerosis	0.000498	0.000587	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000497	0.000586	CcSEcCtD
Melphalan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000496	0.000585	CcSEcCtD
Melphalan—Fatigue—Prednisone—multiple sclerosis	0.000495	0.000584	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00048	0.000566	CcSEcCtD
Melphalan—Infection—Methotrexate—multiple sclerosis	0.000477	0.000562	CcSEcCtD
Melphalan—Asthenia—Dexamethasone—multiple sclerosis	0.000473	0.000558	CcSEcCtD
Melphalan—Asthenia—Betamethasone—multiple sclerosis	0.000473	0.000558	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00047	0.000554	CcSEcCtD
Melphalan—Nausea—Prednisolone—multiple sclerosis	0.000469	0.000554	CcSEcCtD
Melphalan—Pruritus—Dexamethasone—multiple sclerosis	0.000466	0.00055	CcSEcCtD
Melphalan—Pruritus—Betamethasone—multiple sclerosis	0.000466	0.00055	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—multiple sclerosis	0.000466	0.00055	CcSEcCtD
Melphalan—Vomiting—Triamcinolone—multiple sclerosis	0.000462	0.000545	CcSEcCtD
Melphalan—Vomiting—Methylprednisolone—multiple sclerosis	0.000461	0.000544	CcSEcCtD
Melphalan—Rash—Triamcinolone—multiple sclerosis	0.000458	0.00054	CcSEcCtD
Melphalan—Dermatitis—Triamcinolone—multiple sclerosis	0.000458	0.00054	CcSEcCtD
Melphalan—Anorexia—Methotrexate—multiple sclerosis	0.000457	0.00054	CcSEcCtD
Melphalan—Rash—Methylprednisolone—multiple sclerosis	0.000457	0.000539	CcSEcCtD
Melphalan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000457	0.000539	CcSEcCtD
Melphalan—Urticaria—Prednisone—multiple sclerosis	0.000456	0.000538	CcSEcCtD
Melphalan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000451	0.000532	CcSEcCtD
Melphalan—Diarrhoea—Betamethasone—multiple sclerosis	0.000451	0.000532	CcSEcCtD
Melphalan—Hypotension—Methotrexate—multiple sclerosis	0.000448	0.000529	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000437	0.000516	CcSEcCtD
Melphalan—Nausea—Triamcinolone—multiple sclerosis	0.000431	0.000509	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—multiple sclerosis	0.000431	0.000508	CcSEcCtD
Melphalan—Nausea—Methylprednisolone—multiple sclerosis	0.00043	0.000508	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—multiple sclerosis	0.000428	0.000505	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP24A1—multiple sclerosis	0.000426	0.0032	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP27B1—multiple sclerosis	0.000426	0.0032	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—multiple sclerosis	0.000423	0.00318	CbGpPWpGaD
Melphalan—Hypersensitivity—Prednisone—multiple sclerosis	0.000423	0.000499	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—multiple sclerosis	0.000422	0.000498	CcSEcCtD
Melphalan—Vomiting—Dexamethasone—multiple sclerosis	0.000419	0.000494	CcSEcCtD
Melphalan—Vomiting—Betamethasone—multiple sclerosis	0.000419	0.000494	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—multiple sclerosis	0.000417	0.000492	CcSEcCtD
Melphalan—Rash—Betamethasone—multiple sclerosis	0.000416	0.00049	CcSEcCtD
Melphalan—Rash—Dexamethasone—multiple sclerosis	0.000416	0.00049	CcSEcCtD
Melphalan—Dermatitis—Dexamethasone—multiple sclerosis	0.000415	0.00049	CcSEcCtD
Melphalan—Dermatitis—Betamethasone—multiple sclerosis	0.000415	0.00049	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000414	0.000489	CcSEcCtD
Melphalan—Fatigue—Methotrexate—multiple sclerosis	0.000414	0.000488	CcSEcCtD
Melphalan—Asthenia—Prednisone—multiple sclerosis	0.000412	0.000486	CcSEcCtD
Melphalan—Pain—Methotrexate—multiple sclerosis	0.00041	0.000484	CcSEcCtD
Melphalan—Pruritus—Prednisone—multiple sclerosis	0.000406	0.000479	CcSEcCtD
Melphalan—Diarrhoea—Prednisone—multiple sclerosis	0.000393	0.000463	CcSEcCtD
Melphalan—Nausea—Betamethasone—multiple sclerosis	0.000391	0.000462	CcSEcCtD
Melphalan—Nausea—Dexamethasone—multiple sclerosis	0.000391	0.000462	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GPC5—multiple sclerosis	0.00039	0.00293	CbGpPWpGaD
Melphalan—Urticaria—Methotrexate—multiple sclerosis	0.000381	0.00045	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000367	0.00276	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000366	0.00275	CbGpPWpGaD
Melphalan—Vomiting—Prednisone—multiple sclerosis	0.000365	0.000431	CcSEcCtD
Melphalan—Rash—Prednisone—multiple sclerosis	0.000362	0.000427	CcSEcCtD
Melphalan—Dermatitis—Prednisone—multiple sclerosis	0.000362	0.000427	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—multiple sclerosis	0.000353	0.000417	CcSEcCtD
Melphalan—Asthenia—Methotrexate—multiple sclerosis	0.000344	0.000406	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IL2—multiple sclerosis	0.000343	0.00258	CbGpPWpGaD
Melphalan—Nausea—Prednisone—multiple sclerosis	0.000341	0.000402	CcSEcCtD
Melphalan—Pruritus—Methotrexate—multiple sclerosis	0.000339	0.0004	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—multiple sclerosis	0.000328	0.000387	CcSEcCtD
Melphalan—SLC22A3—Metabolism—RRM1—multiple sclerosis	0.000323	0.00243	CbGpPWpGaD
Melphalan—Vomiting—Methotrexate—multiple sclerosis	0.000305	0.00036	CcSEcCtD
Melphalan—Rash—Methotrexate—multiple sclerosis	0.000302	0.000357	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—multiple sclerosis	0.000302	0.000357	CcSEcCtD
Melphalan—Nausea—Methotrexate—multiple sclerosis	0.000285	0.000336	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TGFB1—multiple sclerosis	0.000268	0.00201	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK1—multiple sclerosis	0.000262	0.00197	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000187	0.0014	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BCHE—multiple sclerosis	0.000185	0.00139	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—multiple sclerosis	0.000112	0.000839	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—POMC—multiple sclerosis	9.59e-05	0.000721	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—multiple sclerosis	8.74e-05	0.000657	CbGpPWpGaD
